Incannex to participate in the prestigious h.c. wainwright 24th annual global investment conference

Melbourne, australia, sept. 08, 2022 (globe newswire) -- incannex healthcare limited (nasdaq: ixhl) (asx: ihl), (‘incannex' or the ‘company') a pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic therapies for unmet medical needs, is pleased to announce that it will be featured as a presenting company at the h.c. wainwright 24th annual global investment conference.
IXHL Ratings Summary
IXHL Quant Ranking